Marsh McLennan
MRSH NYSE Insurance Brokers Financials FY2016–FY2025
Marsh McLennan's revenue rose 10.3% to $27.0 billion in fiscal 2025. Its operating margin was 23.1%, down from 23.8% a year earlier. Free cash flow was $5.0 billion, up 25.5%. It paid out $3.7 billion in dividends and buybacks, 74% of free cash flow. The diluted share count fell 0.4%.
What Marsh McLennan does
Marsh McLennan, which in January 2026 shortened its brand name to Marsh, is an insurance broker and consulting firm working with clients in 130 countries. As a broker it helps businesses, governments and individuals buy insurance and manage their risks, and it helps insurance companies buy reinsurance, which is insurance for insurers. Its consultants advise employers on employee health plans, retirement plans and pay, manage investments, and advise companies on strategy, brands and economics.
It has two segments. Risk and Insurance Services, made up of Marsh Risk and the reinsurance broker Guy Carpenter, brought in about 64% of revenue in 2025. It is paid mainly through commissions and fees, and also earns interest on client money it holds, such as premiums. Consulting, made up of Mercer and Marsh Management Consulting, which includes Oliver Wyman, Lippincott and NERA, brought in about 36%, from client fees, insurance commissions and fees based on assets it manages. Mercer managed about $692 billion in assets at the end of 2025. It competes with other insurance brokers, insurers that sell directly, banks, consulting firms and online platforms.
The company has annual revenue of about $27 billion and more than 95,000 employees. It grows partly by buying other firms, including McGriff Insurance Services, which it bought in November 2024 for $7.75 billion.
- Legal name
- MARSH & MCLENNAN COMPANIES, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 9, 2026
- Accession · CIK
- 0000062709-26-000022
0000062709
Revenue and margins
Marsh McLennan had $27.0B of revenue in fiscal 2025, up 10.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 10.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $5.0B in fiscal 2025, 18.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Marsh McLennan returned $3.7B to shareholders in fiscal 2025, 74% of free cash flow. The diluted share count fell 0.4%.
Value Marsh McLennan yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of −$16.9B and divides by 494.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
—
Reference multiples: today 23.6x · peers 21.6x · sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Marsh McLennan can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.8B | $1.4B | $3.4B | $2.4B | $2.7B |
| Debt incl. finance leases | $11.0B | $11.8B | $13.5B | $19.9B | $19.6B |
| Net debt / EBITDA | 1.8x | 2.2x | 1.8x | 2.8x | 2.6x |
| Debt / equity | 1.0x | 1.1x | 1.1x | 1.5x | 1.3x |
| Interest coverage | 9.7x | 9.1x | 9.1x | 8.3x | 6.5x |
| Current ratio | 1.2x | 1.1x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 1.2x | 1.1x | 1.1x | 1.1x | 1.1x |
| Total assets | $44.0B | $44.1B | $48.0B | $56.5B | $58.7B |
| Total liabilities | $23.2B | $33.4B | $35.7B | $42.9B | $43.4B |
| Shareholders' equity | $11.2B | $10.7B | $12.4B | $13.5B | $15.3B |
| Net debt (− = net cash) | $9.2B | $10.3B | $10.1B | $17.5B | $16.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$18.9M
7 insiders
Of sales under plans
68%
$12.9M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | John Q DoylePresident and CEO | Sold plan | 16,656 | $188.51 | $3.1M | Form 4 |
| Sep 2, 2026 | Katherine BrennanSVP and General Counsel | Sold | 1,197 | $187.90 | $0.2M | Form 4 |
| Aug 6, 2026 | John Jude JonesChief Marketing Officer | Sold | 6,500 | $191.96 | $1.2M | Form 4 |
| Jul 29, 2026 | Paul BeswickSVP, Chief Information Officer | Sold plan | 713 | $198.00 | $0.1M | Form 4 |
| Jul 28, 2026 | Martin SouthChief Client Officer | Sold | 7,100 | $189.99 | $1.3M | Form 4 |
| Jul 23, 2026 | Lloyd M YatesDirector | Sold | 12,000 | $175.65 | $2.1M | Form 4 |
| Jun 2, 2026 | John Q DoylePresident and CEO | Sold plan | 16,656 | $161.71 | $2.7M | Form 4 |
| Mar 11, 2026 | John Jude JonesChief Marketing Officer | Sold | 2,362 | $173.61 | $0.4M | Form 4 |
| Mar 4, 2026 | John Q DoylePresident and CEO | Sold plan | 16,655 | $183.30 | $3.1M | Form 4 |
| Mar 3, 2026 | Nicholas Mark StuderPresident and CEO of OWG | Sold | 3,837 | $184.03 | $0.7M | Form 4 |
| Dec 1, 2025 | John Q DoylePresident and CEO | Sold plan | 21,079 | $182.22 | $3.8M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✓ | ✕ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✕ | ✕ | ✓ |
| Current ratio rose | ✓ | ✓ | ✕ |
| Share count didn't rise | ✓ | ✓ | ✓ |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | ✓ | ✕ | ✕ |
| F-score | 7 / 8 | 5 / 8 | 5 / 8 |
| Accruals ratio | −1.1% | −0.5% | −2.0% |
| Altman Z'' | 2.91 | 2.79 | 2.86 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Marsh McLennan MRSH | $94.6B | 10.3% | 23.1% | 18.5% | 15.0% | 23.6x | 5 | |
| Aon AON | $64.9B | 9.5% | 25.3% | 18.7% | 15.6% | 16.7x | 4 | Compare → |
| Arthur J. Gallagher AJG | $68.8B | 20.7% | — | 12.8% | 9.9% | 44.5x | 3 | Compare → |
| Willis Towers Watson WTW | $30.6B | −2.2% | 23.0% | 15.9% | 12.8% | 20.1x | 7 | Compare → |
| Brown & Brown BRO | $24.4B | 22.8% | — | 23.4% | 9.1% | 23.0x | 4 | Compare → |
Stories about Marsh McLennan
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $13.2B | $14.0B | $15.0B | $16.7B | $17.2B | $19.8B | $20.7B | $22.7B | $24.5B | $27.0B |
| Operating income | $2.4B | $2.7B | $2.8B | $2.7B | $3.1B | $4.3B | $4.3B | $5.3B | $5.8B | $6.2B |
| Interest expense | $189M | $237M | $290M | $524M | $515M | $444M | $469M | $578M | $700M | $960M |
| Pretax income | $2.5B | $2.6B | $2.2B | $2.4B | $2.8B | $4.2B | $4.1B | $5.0B | $5.5B | $5.5B |
| Income tax | $685M | $1.1B | $574M | $666M | $747M | $1.0B | $995M | $1.2B | $1.4B | $1.3B |
| Net income | $1.8B | $1.5B | $1.7B | $1.7B | $2.0B | $3.1B | $3.1B | $3.8B | $4.1B | $4.2B |
| Diluted EPS | $3.38 | $2.87 | $3.23 | $3.41 | $3.94 | $6.13 | $6.04 | $7.53 | $8.18 | $8.43 |
| Diluted shares | 0.52B | 0.52B | 0.51B | 0.51B | 0.51B | 0.51B | 0.51B | 0.50B | 0.50B | 0.49B |
| Cash flow | ||||||||||
| Cash from operations | $2.0B | $1.9B | $2.4B | $2.4B | $3.4B | $3.5B | $3.5B | $4.3B | $4.3B | $5.3B |
| Capital expenditure | $253M | $302M | $314M | $421M | $348M | $406M | $470M | $416M | $316M | $291M |
| Free cash flow | $1.8B | $1.6B | $2.1B | $1.9B | $3.0B | $3.1B | $3.0B | $3.8B | $4.0B | $5.0B |
| Depreciation and amortization | $438M | $481M | $494M | $647M | $741M | $747M | $381M | $370M | $369M | $361M |
| Stock-based compensation | $109M | $149M | $193M | $252M | $290M | $348M | $367M | $363M | $368M | $394M |
| Acquisitions | $813M | $655M | $884M | $4.2B | $647M | $859M | $572M | $976M | $8.5B | $652M |
| Share buybacks | $800M | $900M | $675M | $485M | $0.0M | $1.2B | $2.0B | $1.2B | $900M | $2.0B |
| Dividends paid | $682M | $740M | $807M | $890M | $943M | $1.0B | $1.1B | $1.3B | $1.5B | $1.7B |
| Dividends and buybacks | $1.5B | $1.6B | $1.5B | $1.4B | $943M | $2.2B | $3.1B | $2.4B | $2.4B | $3.7B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.0B | $1.2B | $1.1B | $1.2B | $2.1B | $1.8B | $1.4B | $3.4B | $2.4B | $2.7B |
| Total debt | $4.8B | $5.5B | $6.1B | $13.2B | $11.8B | $11.0B | $11.8B | $13.5B | $19.9B | $19.6B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $4.9B | $5.6B | $5.9B | $7.1B | $8.2B | $8.3B | $19.0B | $21.7B | $22.1B | $23.2B |
| Current liabilities | $4.1B | $4.3B | $4.9B | $6.7B | $6.6B | $6.7B | $17.8B | $19.8B | $19.5B | $21.1B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $725M | $712M | $701M | $858M | $856M | $847M | $871M | $882M | $859M | $829M |
| Total assets | $18.2B | $20.4B | $21.6B | $31.4B | $33.0B | $44.0B | $44.1B | $48.0B | $56.5B | $58.7B |
| Total liabilities | $11.9B | $13.0B | $14.0B | $23.4B | $23.8B | $23.2B | $33.4B | $35.7B | $42.9B | $43.4B |
| Shareholders' equity | $6.3B | $7.4B | $7.6B | $7.9B | $9.3B | $11.2B | $10.7B | $12.4B | $13.5B | $15.3B |
| Margins | ||||||||||
| Operating margin | 18.4% | 18.9% | 18.5% | 16.1% | 17.8% | 21.8% | 20.7% | 23.2% | 23.8% | 23.1% |
| EBITDA margin | 21.7% | 22.4% | 21.8% | 20.0% | 22.1% | 25.5% | 22.5% | 24.9% | 25.3% | 24.4% |
| Net margin | 13.4% | 10.6% | 11.0% | 10.5% | 11.7% | 15.9% | 14.7% | 16.5% | 16.6% | 15.4% |
| FCF margin | 13.3% | 11.3% | 14.1% | 11.7% | 17.6% | 15.7% | 14.5% | 16.9% | 16.3% | 18.5% |
| Returns | ||||||||||
| Return on capital | 17.9% | 13.9% | 16.9% | 11.9% | 11.5% | 16.5% | 15.6% | 18.4% | 16.3% | 15.0% |
| Return on capital employed | 17.0% | 17.5% | 16.8% | 13.0% | 12.0% | 13.5% | 13.5% | 19.4% | 17.8% | 16.7% |
| Return on equity | 27.5% | 21.8% | 22.0% | 22.4% | 23.4% | 30.7% | 27.8% | 32.5% | 31.4% | 28.8% |
| Return on assets | 9.7% | 7.7% | 7.9% | 6.6% | 6.3% | 8.2% | 6.9% | 8.2% | 7.8% | 7.2% |
| Growth | ||||||||||
| Revenue growth | — | 6.2% | 6.6% | 11.4% | 3.4% | 15.1% | 4.5% | 9.7% | 7.6% | 10.3% |
| Net income growth | 10.6% | −15.6% | 10.6% | 5.6% | 15.7% | 55.9% | −3.0% | 23.2% | 8.1% | 2.5% |
| EPS growth | 13.4% | −15.1% | 12.5% | 5.6% | 15.5% | 55.6% | −1.5% | 24.7% | 8.6% | 3.1% |
| FCF growth | 12.2% | −9.3% | 32.9% | −8.2% | 56.4% | 2.5% | −3.7% | 28.3% | 3.8% | 25.5% |
| Share count change | −2.2% | −1.0% | −1.5% | 0.0% | 0.2% | 0.2% | −1.6% | −1.2% | −0.6% | −0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.3x | 1.4x | 1.6x | 3.6x | 2.6x | 1.8x | 2.2x | 1.8x | 2.8x | 2.6x |
| Debt / equity | 0.8x | 0.7x | 0.8x | 1.7x | 1.3x | 1.0x | 1.1x | 1.1x | 1.5x | 1.3x |
| Interest coverage | 12.9x | 11.2x | 9.5x | 5.1x | 6.0x | 9.7x | 9.1x | 9.1x | 8.3x | 6.5x |
| Current ratio | 1.2x | 1.3x | 1.2x | 1.1x | 1.2x | 1.2x | 1.1x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 1.2x | 1.3x | 1.2x | 1.1x | 1.2x | 1.2x | 1.1x | 1.1x | 1.1x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.9% | 2.2% | 2.1% | 2.5% | 2.0% | 2.1% | 2.3% | 1.8% | 1.3% | 1.1% |
| Stock comp / revenue | 0.8% | 1.1% | 1.3% | 1.5% | 1.7% | 1.8% | 1.8% | 1.6% | 1.5% | 1.5% |
| Payouts / FCF | 84.5% | 103.1% | 70.1% | 70.9% | 31.1% | 70.3% | 103.1% | 63.7% | 60.5% | 74.2% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 6.0 | 4.0 | 5.0 | 5.0 | 6.0 | 5.0 | 7.0 | 5.0 | 5.0 |
| Altman Z'' | 4.0 | 4.0 | 3.9 | 2.6 | 3.0 | 2.8 | 2.7 | 2.9 | 2.8 | 2.9 |
| Accruals ratio | −1.3% | −2.1% | −3.7% | −2.3% | −4.2% | −1.0% | −0.9% | −1.1% | −0.5% | −2.0% |
Source: SEC EDGAR XBRL filings (CIK 0000062709). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.